drugset / Trial / NCT06359028

Clinical Study to Evaluate the Anti-sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers

NCT06359028

Completed 111 enrolled HALEON
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to confirm the clinical Dentin Hypersensitivity (DH) efficacy of a 0.454 percent (%) Stannous Fluoride (SnF2) toothpaste.

Timeline

Start
2024-03-25
Primary completion
2024-06-20
Completion
2024-06-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluoride Other / unclassified 1100 ppm Topical
Subject Stannous fluoride toothpaste Unknown 0.454 % Topical

Indications